Skip to main content

Table 2 Breast cancer characteristics

From: Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities

 

Control group (n = 25)

HIFU group (n = 25)

p value

Tumor size: mean (range)

2.3~4.5 cm

2.1~4.8 cm

p = NS

Breast cancer TNM staging: n (%)

 

 Stage I

7 (28.0 %)

6 (24.0 %)

p = NS

 Stage IIa

5 (20.0 %)

4 (16.0 %)

 

 Stage IIb

13 (52.0 %)

15 (60.0 %)

 

 Not reported

0 (0.0 %)

0 (0.0 %)

 

Histopathologic grade

 

 G1 well differentiated

12 (48.0 %)

10 (40.0 %)

p = NS

 G2 moderately differentiated

9 (36.0 %)

12 (48.0)%

 

 G3 poorly differentiated

4 (16.0 %)

3 (12.0 %)

 

Receptor status

   

 ER+/PR+

14 (56.0 %)

13 (52.0 %)

p = NS

 ER+/PR−

2 (8.0 %)

4 (16.0 %)

 

 ER−/PR−

8 (32.0 %)

7 (28.0 %)

 

Histological subtype

 

 Infiltrating ductal carcinoma

14 (56.0 %)

13 (52.0 %)

p = NS

 Infiltrating lobular carcinoma

5 (20.0 %)

7 (28.0 %)

 

 Other subtype

6 (24.0 %)

5 (20.0 %)

 

Ipsilateral lymph node metastasis

 

 Sentinel lymph node biopsy

10 (40.0 %)

10 (40 %)

p = NS

 Postoperative permanent pathology

11 (44.0 %)

12 (48 %)

 

 Not reported

0 (0.0 %)

0 (0 %)

 

Lesion location: side

   

 Left side

12 (48.0 %)

14 (56.0 %)

p = NS

 Right side

13 (52.0 %)

11 (44.0 %)

 

Lesion location: vertical

 

 Upper

7 (28.0 %)

9 (36.0 %)

p = NS

 Lower

11 (44.0 %)

10 (40.0 %)

 

 Midline

7 (28.0 %)

5 (20.0 %)

 

Lesion location: horizontal

 

 Upper

7 (28.0 %)

9 (36.0 %)

p = NS

 Lower

11 (44.0 %)

10 (40.0 %)

 

 Midline

7 (28.0 %)

5 (20.0 %)

 
  1. ER+ estrogen receptor positive, ER− estrogen receptor negative, PgR+ progesterone receptor positive, PgR− progesterone receptor negative, cm centimeters, NS nonsignificant